When PD-1 binds to its ligands PD-L1/2, it negatively regulates antigen receptor signaling, suppresses T-cell proliferation, and reduces cytokine production, enabling tumor cells to evade T-cell-mediated immune surveillance.3 Cells expressing PD-L1 are believed to exhibit high proliferative activity.4 The gene discussed is CD274; the disease is neoplasm.